Key result
High-risk clinical characteristics significantly increased STEMI hospital mortality, including heart failure (28.2% vs 7.9% without, p<0.01) and anterior MI (21.4% vs 12.2% for inferior MI, p<0.01).
Why the study?
Does reperfusion therapy reduce hospital mortality in patients with STEMI compared to classical therapy?
Population
2,739 patients with ST elevation myocardial infarction treated in five coronary care units in the Belgrade…
Comparison
Reperfusion therapy vs Classical therapy without reperfusion therapy
Design
Cohort
Follow-up
in-hospital
Authors
Loading...
High-risk STEMI features flag elevated mortality; leaves open reperfusion benefit versus classical therapy in this cohort.
Observational (n=2,739)
Yes
Does reperfusion therapy reduce hospital mortality in patients with STEMI compared to classical therapy?
High-risk clinical characteristics such as older age, female sex, and anterior MI localization significantly increase hospital mortality in STEMI, highlighting the critical need for reperfusion therapy in these vulnerable populations.
Vasiljević et al. (2008) conducted an observational in ST elevation myocardial infarction (STEMI) (n=2,739). High-risk clinical characteristics (e.g., heart failure, anterior MI) vs. Absence of high-risk characteristics was evaluated on Hospital mortality. High-risk clinical characteristics significantly increased STEMI hospital mortality, including heart failure (28.2% vs 7.9% without, p<0.01) and anterior MI (21.4% vs 12.2% for inferior MI, p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: